| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/30/2001 | CA2401226A1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | CA2401219A1 Vertebrate globin |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401036A1 Pyridinylimidazoles |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400952A1 Method of purifying a fermentation broth |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400875A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400823A1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 08/30/2001 | CA2400797A1 Therapeutic agents |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400694A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399442A1 New drug combinations |
| 08/30/2001 | CA2399018A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2396971A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | CA2396960A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | CA2368366A1 Medicament for prevention or treatment of fibrosis having chymase inhibitor as effective ingredient |
| 08/29/2001 | EP1127884A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| 08/29/2001 | EP1127882A1 Tetrazole compounds as thyroid receptor ligands |
| 08/29/2001 | EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation |
| 08/29/2001 | EP1127582A2 Use of cladribine on a stent to prevent restenosis |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127574A1 Use of chitinous materials for inhibiting cellular nitric oxide production |
| 08/29/2001 | EP1127573A1 Compostitions and methods for treating osteoporosis |
| 08/29/2001 | EP1127572A2 Use of flavones for treating cycloxygenase-2 mediated diseases |
| 08/29/2001 | EP1127355A1 Products and methods for brachytherapy |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127071A1 Compounds with growth hormone releasing properties |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1127051A2 Tricyclic pyrazole derivatives |
| 08/29/2001 | EP1126880A2 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 08/29/2001 | EP1126867A2 A composition for the prevention and/or treatment of atherosclerosis |
| 08/29/2001 | EP1126866A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP0666747B1 Use of 17alpha-dihydroequilenin for lowering cholesterol |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310620A Use of glucose uptake enhancer for reducing apoptosis |
| 08/29/2001 | CN1310619A Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 08/29/2001 | CN1310618A Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 08/29/2001 | CN1310613A Rapidly disintegrable solid preparation |
| 08/29/2001 | CN1310019A Maizhenhua extract as coronary heart disease treating medicine and its preparation |
| 08/29/2001 | CN1310018A Compound gingko leaf preparation and its making process |
| 08/29/2001 | CN1310013A Medicine for treating cardiovascular damage caused by systematic lupus erythematosus |
| 08/29/2001 | CN1310000A Combined Chinese and Western medicine for treating cardiopulmonary disease in catabasis |
| 08/29/2001 | CN1309998A Chinese medicine capsule mainly for treating cerebral infraction |
| 08/29/2001 | CN1309994A Pile treating Longzaowan pill |
| 08/29/2001 | CN1309992A Apoplexy curing decoction |
| 08/29/2001 | CN1309991A Chinese herb medicine for treating coronary heart disease |
| 08/29/2001 | CN1309989A Medicine for promoting blood circulation and dispelling wind-evil and its preparation |
| 08/29/2001 | CN1309988A Medicine for regulating the five internal organs and its preparation |
| 08/29/2001 | CN1309985A Chinese medicine health tea capable of lowering blood pressure and blood lipoid |
| 08/29/2001 | CN1309984A Biological preparation for preventing and treating cardio-and cerebro-vascular disease and diabetes, nursing face and invigorating kidney and its preparation process |
| 08/29/2001 | CN1309980A Pile treating medicine powder |
| 08/29/2001 | CN1309969A Application of ginsenoside Rg2 in preparing medicine for cardio-and cerebro-vascular disease |
| 08/29/2001 | CN1309968A Pharmaceutical application of froctose biphosphate magnesium |
| 08/29/2001 | CN1070183C Intermediate for producing triterpene derivatives |
| 08/29/2001 | CN1070176C 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/29/2001 | CN1070074C Medicinal tea for treating hypertension |
| 08/29/2001 | CN1070071C Chinese herb medicine for treating piles and anal fistula |
| 08/29/2001 | CN1070058C Medicine for treating inflammatory piles |
| 08/28/2001 | US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders |
| 08/28/2001 | US6281246 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 08/28/2001 | US6281225 Inhibiting proliferation of arterial smooth muscle cells |
| 08/28/2001 | US6281206 Amidino and benzamidino compounds |
| 08/28/2001 | US6281199 Method of treatment of heart disease caused by Chlamydia pneumoniae |
| 08/28/2001 | US6281194 E.g., (s)-(1-((4-benzyloxy-benzyl)-(((1-phenyl-cyclobutylmethyl)-car bamoyl)-methyl)-carbamoyl)-2-(1h-imidazol-4-yl)-ethyl)-carbami c acid benzyl ester |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280969 Growth arrest homeobox gene |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | CA2217888C Triacetin as a transdermal penetration enhancer |
| 08/28/2001 | CA2107552C Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 08/28/2001 | CA2015996C Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals |
| 08/25/2001 | CA2337565A1 Use of cladribine on a stent to prevent restenosis |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |